Combinations of drugs could hold the key to overcoming some of the biggest challenges in lung and other cancers.

Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.

Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.

Pneumatic tube systems have existed for 150+ years and have transported everything from telegrams to aircraft parts. Now they’re being used in our labs.

In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Cardiovascular researcher Jennifer Allport-Anderson describes the personal qualities and decisions that have made her a successful leader.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

Jean Silveri shares key insights from her legal career.